Article Versions Notes

Togashi K, Suzuki S, Mitobe Y, Nakagawa-Saito Y, Sugai A, Takenouchi S, Sugimoto M, Kitanaka C, Okada M. CEP-1347 Dually Targets MDM4 and PKC to Activate p53 and Inhibit the Growth of Uveal Melanoma Cells. Cancers. 2024; 16(1):118. https://doi.org/10.3390/cancers16010118

Togashi, Keita, Shuhei Suzuki, Yuta Mitobe, Yurika Nakagawa-Saito, Asuka Sugai, Senri Takenouchi, Masahiko Sugimoto, Chifumi Kitanaka, and Masashi Okada. 2024. "CEP-1347 Dually Targets MDM4 and PKC to Activate p53 and Inhibit the Growth of Uveal Melanoma Cells" Cancers 16, no. 1: 118. https://doi.org/10.3390/cancers16010118

Togashi, K., Suzuki, S., Mitobe, Y., Nakagawa-Saito, Y., Sugai, A., Takenouchi, S., Sugimoto, M., Kitanaka, C., & Okada, M. (2024). CEP-1347 Dually Targets MDM4 and PKC to Activate p53 and Inhibit the Growth of Uveal Melanoma Cells. Cancers, 16(1), 118. https://doi.org/10.3390/cancers16010118